FAR2 | Fatty acyl CoA reductase 2 | Enzymes Predicted membrane proteins
| | | | | Mixed |
FPR2 | Formyl peptide receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FXYD7 | FXYD domain containing ion transport regulator 7 | Predicted membrane proteins
| | | | | Tissue enriched |
G6PC | Glucose-6-phosphatase, catalytic subunit | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
GABRA2 | Gamma-aminobutyric acid (GABA) A receptor, alpha 2 | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
GABRE | Gamma-aminobutyric acid (GABA) A receptor, epsilon | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
GABRG3 | Gamma-aminobutyric acid (GABA) A receptor, gamma 3 | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GABRP | Gamma-aminobutyric acid (GABA) A receptor, pi | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GIPR | Gastric inhibitory polypeptide receptor | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GJA9 | Gap junction protein, alpha 9, 59kDa | Predicted membrane proteins
| | | | | Tissue enhanced |
GJC3 | Gap junction protein, gamma 3, 30.2kDa | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GLP2R | Glucagon-like peptide 2 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GLRA4 | Glycine receptor, alpha 4 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GOLT1B | Golgi transport 1B | Predicted membrane proteins
| | | | | Expressed in all |
GPAT2 | Glycerol-3-phosphate acyltransferase 2, mitochondrial | Enzymes Predicted membrane proteins
| | | | | Mixed |
GPM6B | Glycoprotein M6B | Predicted membrane proteins
| | | | | Tissue enriched |
GPR1 | G protein-coupled receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPR108 | G protein-coupled receptor 108 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
GPR133 | G protein-coupled receptor 133 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
GPR137 | G protein-coupled receptor 137 | Predicted membrane proteins
| | | | | Expressed in all |
GPR137B | G protein-coupled receptor 137B | Predicted membrane proteins Transporters
| | | | | Mixed |
GPR143 | G protein-coupled receptor 143 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins
| | | | | Mixed |
GPR160 | G protein-coupled receptor 160 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
GPRC5B | G protein-coupled receptor, family C, group 5, member B | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPRC5C | G protein-coupled receptor, family C, group 5, member C | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Expressed in all |
GRIA1 | Glutamate receptor, ionotropic, AMPA 1 | FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
GRIA2 | Glutamate receptor, ionotropic, AMPA 2 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
GRIA3 | Glutamate receptor, ionotropic, AMPA 3 | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
GRID2 | Glutamate receptor, ionotropic, delta 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
GRIK1 | Glutamate receptor, ionotropic, kainate 1 | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
GRIK2 | Glutamate receptor, ionotropic, kainate 2 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GRIK3 | Glutamate receptor, ionotropic, kainate 3 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
GRIN1 | Glutamate receptor, ionotropic, N-methyl D-aspartate 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins Transporters
| | | | | Tissue enriched |
GRIN2A | Glutamate receptor, ionotropic, N-methyl D-aspartate 2A | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
GRINA | Glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) | Predicted membrane proteins
| | | | | Expressed in all |
GSG1 | Germ cell associated 1 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
GSG1L | GSG1-like | Predicted membrane proteins
| | | | | Tissue enhanced |
HEATR5A | HEAT repeat containing 5A | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
HGSNAT | Heparan-alpha-glucosaminide N-acetyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
HMGCR | 3-hydroxy-3-methylglutaryl-CoA reductase | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
HVCN1 | Hydrogen voltage-gated channel 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
IGSF1 | Immunoglobulin superfamily, member 1 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ITPR1 | Inositol 1,4,5-trisphosphate receptor, type 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
KCNA2 | Potassium voltage-gated channel, shaker-related subfamily, member 2 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KCNJ12 | Potassium inwardly-rectifying channel, subfamily J, member 12 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KCNK2 | Potassium channel, subfamily K, member 2 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KIAA0195 | KIAA0195 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
KRTCAP3 | Keratinocyte associated protein 3 | Predicted membrane proteins
| | | | | Mixed |
LAPTM4B | Lysosomal protein transmembrane 4 beta | Predicted membrane proteins Transporters
| | | | | Expressed in all |